RSS Items

CDC has awarded $155 million in new funding to states and four U.S. territories to advance the understanding of the opioid overdose epidemic and to scale-up prevention and response activities, including improving the timeliness and quality of

CDC will host a media telebriefing today to discuss the on-going outbreak of Ebola in West Africa. There is no significant risk in the U.S. While it is unlikely that the disease would spread if imported into the United States, the recent infections

CDC will host a media telebriefing today to discuss the on-going outbreak of Ebola in West Africa. There is no significant risk in the U.S. While it is unlikely that the disease would spread if imported into the United States, the recent infections

CDC will host a media telebriefing today to discuss Enterorvirus D68, the respiratory illness affecting children in multiple states.

CDC will host a media telebriefing today to discuss Enterorvirus D68, the respiratory illness affecting children in multiple states.

Today, following a thorough reassessment, the CDC Director is issuing a Public Health Determination and terminating an Order under 42 U.S.C. §§ 265, 268 and 42 C.F.R. § 71.40 (i.e., "Title 42"), suspending the right to introduce migrants into the

Today, following a thorough reassessment, the CDC Director is issuing a Public Health Determination and terminating an Order under 42 U.S.C. §§ 265, 268 and 42 C.F.R. § 71.40 (i.e., "Title 42"), suspending the right to introduce migrants into the

The first national study to look at behavioral therapy, medication, and dietary supplements to treat attention-deficit/hyperactivity disorder (ADHD) among children ages 4-17 shows that less than one half of children with ADHD were receiving

The first national study to look at behavioral therapy, medication, and dietary supplements to treat attention-deficit/hyperactivity disorder (ADHD) among children ages 4-17 shows that less than one half of children with ADHD were receiving

A new CDC study provides strong evidence that mRNA COVID-19 vaccines are highly effective in preventing SARS-CoV-2 infections in real-world conditions among health care personnel, first responders, and other essential workers.